Hyperglycaemia increases the risk of COVID-19 mortality in people without diabetes by almost double, when compared to those with diabetes

According to recent study results, hyperglycaemia has been recognised as an “independent risk factor for mortality” for people with COVID-19.

Hyperglycaemia has been found to pose nearly double the risk of mortality to people with COVID-19 who do not have diabetes, despite diabetes being distinguished as a risk factor for individuals with COVID-19.

The study suggests that the mortality risk in people with COVID-19 who have been admitted to hospital can be adapted and improved using glucose control.

The research surveyed data from 74,148 people with, and without, pre-existing diabetes who had tested positive for COVID-19 and were admitted to hospital.

Statistics from one or more glucose measurement per individual were assessed to investigate and identify the link between hyperglycaemia and poor outcomes.

A hyperglycaemic measurement during their time in hospital was associated with a higher risk of morality when compared to those who had glucose measurements that were within the “normal range”.

The risk of mortality for people with pre-existing diabetes increased by 10.1% when they had a glucose measurement classified as hyperglycaemic. Whereas risk for individuals without pre-existing diabetes increased by 18.4%, the study said.

Nevertheless, COVID-19 mortality is still higher in people with diabetes, whether hyperglycaemia was detected or not.

Photo by CDC on Unsplash

Customer Reviews


    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

    Thanks for submitting your comment!